Your Next Chapter in 3 Simple Steps Tell us about your preferences, goals, and health
Novo Nordisk announced FDA acceptance of their New Drug Application (NDA) for a 25 mg oral version of Wegovy for two new indications: (1) chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition, and (2) to reduce the risk of major adverse cardiac events (MACE) in adults with overweight or obesity and established CVD
16 Hims & Hers Health, a U.S.-based telemedicine company, has recently announced future plans to provide GLP-1RA drugs as part of its new weight-loss platform, alongside personalized nutrition guidance, digital tracking tools, mental health support, etc
I know that there are some people who love sermorelin and don't see any of the same issues
Challenges and promises for the development of donor-independent platelet transfusions